Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification
From MaRDI portal
Publication:3800950
DOI10.2307/2531201zbMath0654.62088WikidataQ47205739 ScholiaQ47205739MaRDI QIDQ3800950
Mary A. Foulkes, John M. Lachin
Publication date: 1986
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2531201
stratification; noncompliance; sample size; power; clinical trial; log-rank test; loss to follow-up; equality of survival distributions; prognostic covariates
62P10: Applications of statistics to biology and medical sciences; meta analysis
Related Items
Sample Size Estimation for Survival Outcomes in Cluster‐Randomized Studies with Small Cluster Sizes, Information and information fractions for design and sequential monitoring of clinical trials, Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints, Sample size calculations for noninferiority trials for time-to-event data using the concept of proportional time, GenTwoArmsTrialSize, On the empirical choice of the time window for restricted mean survival time, Sample size estimation for cancer randomized trials in the presence of heterogeneous populations, Sample size calculation for two‐arm trials with time‐to‐event endpoint for nonproportional hazards using the concept of Relative Time when inference is built on comparing Weibull distributions, Sample size determination in superiority or non-inferiority clinical trials with time-to-event data under exponential, Weibull and Gompertz distributions, Optimal treatment allocation and study duration for trials with discrete-time survival endpoints, On lachin'S formulae for sample sizes of survival tests, Calculation of Sample Size in Survival Trials: The Impact of Informative Noncompliance
